The Quarter in Context

For the three months ended August 31, 2026, Constellation Brands reported net sales of $2,633.0 million, up 6.1% from $2,481.0 million in the prior-year quarter, with cost of product sold rising to $1,240.0 million and gross profit expanding to $1,393.0 million. The gross margin of 52.9% sits modestly above the 52.8% posted a year earlier, evidence that pricing and mix held up against input cost pressure. Operating income of $805.0 million was lower than the $874.0 million reported in the prior-year quarter, in part because the current quarter absorbed $49.8 million of asset impairment and related expenses that the prior-year quarter did not. The $17.6 million operating-income decline therefore reflects a reported charge, not an underlying deterioration in demand economics.
Below the operating line, interest expense of $83.4 million versus $87.6 million shows modest relief from financing costs, and the effective tax rate of approximately 20.2% (computed from $147.1 million of tax on $729.4 million of pretax income) compares with a much higher 37.9% in the prior-year quarter, which had been distorted by deferred-tax movements. Net income attributable to the parent of $565.8 million was 21.4% above the $466.0 million earned a year earlier, despite the impairment charge, lifting trailing-twelve-month net income to roughly $1.92 billion.
Business Model and Profit Engine
Constellation Brands earns revenue primarily by selling branded beverage alcohol through U.S. wholesalers, retailers, state alcohol beverage control agencies, and direct-to-consumer channels. The customer pays a net wholesale price that carries a built-in excise tax (excluded from net sales per the filing), with the company's realized revenue reflecting gross sales net of promotions, returns, and allowances. Recurring, replenishment-based demand for beer is the core transactional pattern, complemented by what remains of the wine and spirits portfolio after the June 2025 mainstream wine divestiture and the June 2026 New Zealand wine divestiture. Customers in the three-tier U.S. distribution channel rely on the company's brands because shelf placement, consumer pull, and licensed trademarks are difficult and expensive to replicate, which is the principal economic engine visible in the filing.
The revenue-to-profit conversion passes through several distinct cost layers. Cost of product sold of $1,240.0 million in Q2 FY27 represented 47.1% of net sales, a fixed and semi-variable layer that includes raw materials (aluminum, glass, agricultural inputs), production labor, and brewery overhead. Selling, general, and administrative expenses of $538.2 million (20.4% of net sales) cover marketing, sales force, and corporate overhead, and these costs rose from $436.0 million a year earlier, an expense mix shift that is one observable pressure on operating income. Asset impairment of $49.8 million is a non-recurring item that reduced reported operating income but does not affect ongoing cash production.
The balance-sheet architecture is capital-intensive but cash-generative. Property, plant, and equipment of $8,653.2 million against $22,063.7 million of total assets signals heavy reinvestment in Mexican brewery capacity (Nava, Obregón, and the Veracruz project). Inventory of $1,378.6 million and accounts receivable of $678.1 million indicate modest working-capital absorption, and operating cash flow of $1,478.6 million over the six months ended August 31, 2026 covered both capital expenditure of $354.1 million and dividend payments of $353.8 million, with treasury repurchases of $454.7 million absorbing additional cash. Customer concentration is not disclosed in the cited excerpts, and segment-level economics are not extracted in the available filings text; this is a data gap that limits full granularity on revenue mix between beer and wine/spirits.
Earnings Quality and Cash Conversion
Where the issuer reports cash flow and capital expenditure cumulatively, the standalone-quarter cash-flow figures are derived by subtracting the preceding cumulative filing. They are calculations from SEC facts rather than separately reported quarterly line items.
Reported net income of $565.8 million in Q2 FY27 is supported by $1,478.6 million of operating cash flow over the six months ended August 31, 2026, which exceeded the $1,489.3 million generated in the prior-year comparable period. Trailing-twelve-month operating cash flow of approximately $2.66 billion, combined with trailing-twelve-month capital expenditure of roughly $819 million, produces a derived trailing free-cash-flow proxy of about $1.84 billion. The 12.6% decline in trailing operating cash flow is an analytical concern: most of the change sits in the timing of other accrued expenses and liabilities, which moved negatively by $197.9 million in the current six-month period versus a smaller $57.0 million a year earlier. That is a working-capital headwind, not a profitability deterioration, but it does illustrate that GAAP earnings and cash earnings can diverge quarter to quarter.
Stock-based compensation of $34.9 million over the six months ended August 31, 2026 is small relative to net income of $1,254.2 million for the same period, so share-based payment dilution does not distort the headline economics meaningfully. Asset impairment of $68.1 million in the six-month period is a non-cash add-back, and the $5.5 million of restructuring costs recognized within selling, general, and administrative expenses are part of the 2025 Restructuring Initiative, with $127.4 million cumulative pre-tax costs incurred through August 31, 2026. Deferred tax provision of $26.8 million over the six months compares with $277.6 million a year earlier, explaining most of the year-over-year reduction in the tax provision; this is a comparative timing item, not an underlying earnings-quality flag.
The accounting free-cash-flow proxy (operating cash flow minus total capital expenditure, with no separation of maintenance from growth capex) is $1,124.5 million over the six months ended August 31, 2026, calculated as $1,478.6 million of operating cash flow minus $354.1 million of capex. This is the author's derived figure; the filing does not label it "free cash flow," and the brewery expansion capex at Nava, Obregón, and Veracruz means a meaningful portion is growth-oriented rather than maintenance. The limitation matters: the conservative buyer should assume a portion of capex is discretionary and could be deferred in a downturn, but the filings do not quantify that split.
Business Quality, Moat, and Industry Position
Constellation Brands' economic moat, as observable in the filings, rests on licensed and owned trademarks in U.S. high-end imported beer, an exclusive sub-license agreement with Marcas Modelo dating to 2013, and the marketing and distribution scale required to secure shelf placement in the U.S. beer category. The company identifies a U.S. leadership position in the high-end beer segment and references Circana, Beer Marketers Insights, and IWSR as third-party sources for market position data, though those publications are not reproduced here and therefore cannot be independently verified. The competitive set in beer includes multinational brewers; in wine and spirits, after the divestitures, the remaining portfolio is positioned for higher-margin, smaller-volume premium placements.
The three-tier U.S. distribution channel (producer to wholesaler to retailer, with state governments playing wholesaler and retailer roles in control states) creates a structural barrier: any new entrant must build relationships across thousands of distributors and retailers, and shelf real estate is finite. This is not a legal barrier; it is a scale and relationship moat that is observable from the filing language about distributor and retailer reliance. The company is exposed to consumer-discretionary cyclicality in alcohol demand, to regulatory and tax policy changes (the filing references potential impacts of the One Big Beautiful Bill Act, tariffs under Section 232, and global minimum tax), and to commodity input costs (aluminum, corn, diesel, natural gas). The 2025 Restructuring Initiative and the wine divestitures are evidence that management is actively narrowing the portfolio to focus capital on the higher-return beer franchise.
A demand-side weakness would weaken the moat: if U.S. consumers shift away from high-end imports toward domestic value beer, ready-to-drink cocktails, or non-alcoholic alternatives, the company's net-sales growth could compress. The filing flags declines in alcohol consumption as a forward-looking-statement risk. No supply-chain bottleneck classification has been independently verified in the available evidence; the company is an upstream producer and a midstream brand owner simultaneously, so the role is best described as an important participant in a competitive oligopoly rather than a sole bottleneck at any single link.
Management and Capital Allocation
Capital allocation over the trailing twelve months shows a clear pattern: $774.8 million of share repurchases, $708.4 million of dividends, $603.6 million of long-term debt principal paid (at fiscal-year end), and $272.0 million of short-term borrowings repaid. The 2025 Authorization permits up to $4.0 billion of buybacks through February 29, 2028, and $2,621.2 million remained available as of August 31, 2026, signaling that the buyback program is far from exhausted. The combination of dividends plus repurchases ($1,483.2 million trailing) is more than the trailing-twelve-month free-cash-flow proxy of $1.84 billion, leaving modest headroom for debt reduction and capex. Treasury stock grew from $8,103.0 million at February 28, 2026 to $8,529.8 million at August 31, 2026, consistent with active repurchases at an average price of $135.49 per share in the latest quarter.
Management completed a CEO transition: Nicholas I. Fink's employment agreement is effective February 10, 2026, replacing William A. Newlands, and the filing lists a Transition Agreement with Newlands dated February 10, 2026. A leadership change is a risk to monitor but is not itself an adverse signal; the disclosed employment agreements and the disclosed succession structure are observable evidence of formal governance rather than informal or abrupt change. Stock-based compensation at $19.98 million in Q2 FY27 is small relative to operating income of $805.0 million, so management incentives are not misaligned through excessive option overhang. The 2025 Restructuring Initiative, with cumulative pre-tax costs of $127.4 million through August 31, 2026 and an estimated total of $130 million, signals a controlled cost-out effort, with most of the work already executed in fiscal 2026.
There is no evidence in the available filings of value-destructive acquisitions. The SpikedAde acquisition and contingent-consideration arrangements are flagged as forward-looking risks, but the magnitude is not disclosed in the available text, so a complete judgment on acquisition discipline cannot be made from the available evidence. Wine divestiture proceeds of $851.1 million in the prior-year six-month period, against a $100 million current-six-month figure, show that the company has been actively reshaping the portfolio.
Valuation and What the Market Already Expects
The dated market capitalization is $20,218.5 million as of October 8, 2026, at a share price of $118.39. Against trailing-twelve-month net income of $1,924.2 million, the implied P/E ratio of approximately 10.5 is a defensible rough sensitivity if the reader treats TTM net income as a proxy for run-rate earnings, but this is not a forward P/E and does not reflect forward earnings revisions. Operating cash flow yield is approximately 13.2% ($2,658.3 million against the dated market capitalization), and the trailing free-cash-flow proxy yield is approximately 9.1% ($1,839.3 million against the dated market capitalization). Total debt of $10,315.7 million against cash of $98.5 million gives a net-debt position of roughly $10.22 billion, so enterprise value is approximately $30.43 billion, an EV/EBIT multiple that the available evidence does not calculate directly.
The dated market capitalization lies within a narrow band of the deterministic base scenario, suggesting that the current price already discounts a path of modest free-cash-flow growth and stable margins. The reverse-DCF logic implicit in the dated market cap is that the market is paying for normalized owner earnings that continue to grow at a low single-digit rate rather than the company's historical mid-single-digit revenue growth, and the implied growth rate that the market is underwriting is below the recent observed 6.1% year-over-year revenue growth. This is not a statement of an intrinsic fair value; it is a description of what the market price appears to require. A conservative reader should treat the current price as fairly valued rather than as an obvious bargain, especially given the leverage.
The balance-sheet adjustment is significant: subtracting $10.22 billion of net debt from a $30.43 billion enterprise value leaves equity at approximately $20.22 billion, which equals the dated market capitalization. The reader should note that the valuation analysis framework already incorporates this same-date net-cash bridge, so the equity-versus-enterprise-value math is internally consistent rather than a double-counting. The valuation burden on the company is real: any meaningful multiple compression at the dated price would require earnings deterioration, not just slower growth.
Ten-Year Cash Flow to Fair Market Value
The starting free cash flow is the normalized SEC cash-flow proxy, while every growth rate, discount rate and terminal rate below is an explicit editorial assumption rather than company guidance. Each annual cash flow is forecast and discounted separately; terminal value is year-ten free cash flow multiplied by one plus terminal growth, divided by discount rate minus terminal growth, and then discounted back ten years. Fair market capitalization equals that explicit ten-year present value plus discounted terminal value and a same-date balance-sheet adjustment when available. If current cash and debt facts do not share one report date, the table shows the adjustment as unavailable and conservatively applies zero. The share count is derived from the dated market capitalization and share price so US shares and foreign ADRs use a consistent traded-security denominator.
Year | Bear FCF | Base FCF | Bull FCF |
|---|---|---|---|
1 | $1.8B | $1.91B | $2.02B |
2 | $1.77B | $1.99B | $2.23B |
3 | $1.73B | $2.07B | $2.45B |
4 | $1.7B | $2.15B | $2.69B |
5 | $1.66B | $2.24B | $2.96B |
6 | $1.68B | $2.3B | $3.11B |
7 | $1.71B | $2.37B | $3.27B |
8 | $1.73B | $2.45B | $3.43B |
9 | $1.75B | $2.52B | $3.6B |
10 | $1.78B | $2.59B | $3.78B |
Scenario | Growth years 1–5 / 6–10 | Discount | Terminal | 10-year PV | Terminal PV | Balance-sheet adjustment | Fair market cap | Fair value/share | Margin of safety | Terminal share |
|---|---|---|---|---|---|---|---|---|---|---|
Bear | -2.0% / 1.3% | 11.0% | 2.0% | $10.2B | $7.09B | -$10.2B | $7.09B | $41.5 | -185.4% | 41.0% |
Base | 4.0% / 3.0% | 9.0% | 3.0% | $14.2B | $18.8B | -$10.2B | $22.8B | $133 | 11.2% | 57.1% |
Bull | 10.0% / 5.0% | 8.5% | 3.5% | $18.5B | $34.6B | -$10.2B | $42.9B | $251 | 52.9% | 65.1% |
In the reverse-DCF, holding the 9% discount rate and 3% terminal growth fixed, and solving only for one constant growth rate rather than using the base-case growth path, the current market capitalization implies roughly 2.5% annual free cash flow growth for ten years. This is a sensitivity framework, not a price target: the terminal-value share shows how strongly each result depends on assumptions beyond the explicit forecast. Negative margin of safety means the current market capitalization exceeds the scenario value.
Five Value-Investing Lenses
Benjamin Graham Lens
Graham's discipline is to test whether a stock price offers a margin of safety against a worst-case earnings decline and balance-sheet stress. Constellation Brands enters the test with a tangible book value of $3.30 billion, well below the dated $20.22 billion market capitalization, so the price is not Graham-cheap on a net-asset basis. The current ratio of $2,959.5 million in current assets against $2,963.8 million in current liabilities is essentially one-to-one, which is tight but supported by $2.25 billion of revolving credit capacity under the 2025 Credit Agreement. Total debt of $10.32 billion against $8.59 billion of stockholders' equity means leverage is approximately 1.2x book equity; if free cash flow fell to zero, debt service would have to come from refinancing rather than from operations, which is a real-world risk in a credit-market shock.
Benjamin Franklin Lens
The Franklin lens here is a modern application of thrift, discipline, compounding, and opportunity cost rather than a claim that Franklin analyzed securities. Constellation's capital allocation demonstrates discipline in three observable ways: dividends are paid from operating cash flow rather than from new debt; share repurchases at an average price of $135.49 in the latest quarter occurred when the stock was already trading near recent highs, which is a modest warning about price discipline; and the brewery capex program is sequenced over multiple years rather than concentrated in a single period, preserving financial flexibility. The opportunity cost of the buyback program is the forgone debt paydown: at a roughly 4.5%-5% all-in cost of debt (per the senior notes coupons disclosed in the filing), every dollar of buyback at $135 carries an opportunity cost of an avoided interest expense of about $4.50-$5.00.
Warren Buffett Lens
Buffett would ask whether normalized owner earnings, treated conservatively, justify the equity price after the net-debt bridge. The accounting free-cash-flow proxy of $1.84 billion over the trailing twelve months is the author's derived figure and is the right starting point for owner earnings, but it does not separate maintenance from growth capex, so the conservative reader should assume the true maintenance owner earnings are lower. Adding back stock-based compensation of $70.5 million over the trailing twelve months and treating the $68.1 million of asset impairment in the six-month period as non-recurring produces a normalized owner earnings of roughly $1.97 billion before any further capex adjustment. Buffett would also test capital allocation: the 2025 buyback authorization at $135 average cost is reasonable if intrinsic value is above $135, but the filing does not disclose management's intrinsic-value estimate, so this remains an inferential judgment.
Charlie Munger Lens
Munger would invert the question and ask how this investment could lose money permanently. The most plausible loss paths are: a sustained decline in U.S. high-end beer demand that compresses both volume and pricing power; a major brewery disruption at Nava or Obregón, where production is concentrated; a litigation outcome in the pending securities class action (the Low v. Constellation Brands case) that produces a material settlement; and a tariff or trade-policy shock that raises input costs faster than pricing can be passed through. Munger would also test the incentive structure: the CEO transition agreement with Newlands and the new agreement with Fink are observable in the filing, but the magnitude of any change-in-control payments or unvested equity acceleration is not disclosed in the cited excerpts.
Li Lu Lens
Li Lu's framework asks whether the company sits inside the investor's circle of competence, whether the cultural moat is real, and whether the durable advantage can survive a decade of change. Constellation Brands is a consumer-staples-adjacent business with a portfolio concentration in U.S. high-end imported beer; understanding that category requires only modest domain knowledge, so it sits inside the circle of competence for most fundamental investors. The cultural moat is harder to verify from the filings: management has executed a clear portfolio-shaping strategy (wine divestitures, brewery capex, restructuring initiative), but the filings do not include direct evidence of employee retention, customer-survey data, or supplier-relationship depth.
Risks, Disconfirming Evidence, and What Would Prove This Thesis Wrong
Three observable thesis breakers would force a re-evaluation. First, a sustained decline in U.S. high-end beer volumes or pricing would compress the gross margin from the current 52.9% level; the 10-Q itself flags declines in alcohol consumption as a forward-looking risk, and a two-quarter trend of negative depletion growth at constant currency would be the first observable signal. Second, a meaningful adverse outcome in the Low v. Constellation Brands securities litigation or in the related derivative complaints could produce a settlement or judgment large enough to impair the balance sheet; the case is in motion-to-dismiss stage with oral argument held July 22, 2026, so an adverse ruling within the next two to four quarters is the next decision point.
The most likely wrong assumption in any bullish thesis is that beer demand growth will continue at the recent mid-single-digit rate. The 10-K language about consumer-discretionary weakness, value-seeking behavior, and economic uncertainty is observable evidence that demand could soften without warning. The opportunity cost of buying at $118.39 is the return available in higher-quality staples trading at lower multiples; the available evidence does not include peer multiples, so a peer-comparison judgment is not made here. A confirmation event would be two consecutive quarters of high-single-digit net-sales growth at constant currency with stable gross margins; a falsification event would be a single quarter of negative U.S. depletion growth combined with an operating-margin contraction of more than 100 basis points.
The reverse-DCF logic of the dated market capitalization is that the market is paying for normalized owner earnings that grow at roughly the rate consistent with the base-scenario assumptions; if the company delivers below the base-scenario free-cash-flow growth path, the dated price offers no margin of safety. The available evidence does not include management's own long-term guidance, so the analyst's view of normalized free cash flow is a judgment rather than a company-confirmed forecast. A conservative reader should treat the current price as fairly valued rather than as an obvious bargain and should require either a price decline or evidence of accelerating free-cash-flow growth before increasing the position.
Investment Conclusion
Constellation Brands at $118.39 is a quality franchise with steady demand, durable margins, and disciplined capital allocation, but the dated $20.22 billion market capitalization is approximately in line with a conservative base-scenario valuation, leaving little margin of safety at the current price. The 52.9% gross margin, the 30.6% operating margin, and the trailing-twelve-month free-cash-flow proxy of $1.84 billion are observable evidence that the profit engine is intact, while the $10.32 billion of total debt is a real constraint on equity-holder returns if demand softens. The investment conclusion is fairly valued: the dated price reflects a reasonable base case but does not provide the cushion a margin-of-safety buyer would require, and the dated market data cap carries no independent upside that is not already implicit in the deterministic base scenario.
This article is for educational and informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. All figures are derived from the available SEC filings and the dated market snapshot; the valuation analysis scenarios are author-constructed and are not stated forecasts. Past performance does not guarantee future results.
Share this article







